These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27692539)

  • 1. Macrophage/monocyte-specific deletion of Ras homolog gene family member A (RhoA) downregulates fractalkine receptor and inhibits chronic rejection of mouse cardiac allografts.
    Liu Y; Chen W; Wu C; Minze LJ; Kubiak JZ; Li XC; Kloc M; Ghobrial RM
    J Heart Lung Transplant; 2017 Mar; 36(3):340-354. PubMed ID: 27692539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening RhoA/ROCK inhibitors for the ability to prevent chronic rejection of mouse cardiac allografts.
    Chen W; Chen S; Chen W; Li XC; Ghobrial RM; Kloc M
    Transpl Immunol; 2018 Oct; 50():15-25. PubMed ID: 29885441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Siponimod (Mayzent) Downregulates RhoA and Cell Surface Expression of the S1P1 and CX3CR1 Receptors in Mouse RAW 264.7 Macrophages.
    Uosef A; Vaughn N; Chu X; Elshawwaf M; Abdelshafy AAA; Elsaid KMK; Ghobrial RM; Kloc M
    Arch Immunol Ther Exp (Warsz); 2020 Jun; 68(3):19. PubMed ID: 32488676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Fractalkine-CX3CR1 Axis in Acute Rejection of Mouse Heart Allografts Subjected to Ischemia Reperfusion Injury.
    Kanzawa T; Tokita D; Saiga K; Yamakawa T; Ishigooka H; Fukuda H; Katsumata H; Miyairi S; Ishii R; Hirai T; Imai T; Okumi M; Tanabe K
    Transpl Int; 2022; 35():10157. PubMed ID: 35185378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockout of microRNA-155 ameliorates the Th1/Th17 immune response and tissue injury in chronic rejection.
    Zhang A; Wang K; Zhou C; Gan Z; Ma D; Ye P; Sun Y; Wu J; Huang X; Ren L; Deng P; Wu C; Yue Z; Ding X; Chen J; Xia J
    J Heart Lung Transplant; 2017 Feb; 36(2):175-184. PubMed ID: 27296836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Divergent role of donor dendritic cells in rejection versus tolerance of allografts.
    Ueno T; Tanaka K; Jurewicz M; Murayama T; Guleria I; Fiorina P; Paez JC; Augello A; Vergani A; Wong M; Smith RN; Abdi R
    J Am Soc Nephrol; 2009 Mar; 20(3):535-44. PubMed ID: 19129312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pioglitazone prevents acute and chronic cardiac allograft rejection.
    Kosuge H; Haraguchi G; Koga N; Maejima Y; Suzuki J; Isobe M
    Circulation; 2006 Jun; 113(22):2613-22. PubMed ID: 16735678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage subpopulations and their impact on chronic allograft rejection versus graft acceptance in a mouse heart transplant model.
    Zhao Y; Chen S; Lan P; Wu C; Dou Y; Xiao X; Zhang Z; Minze L; He X; Chen W; Li XC
    Am J Transplant; 2018 Mar; 18(3):604-616. PubMed ID: 29044999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ROCK inhibition impedes macrophage polarity and functions.
    Liu Y; Tejpal N; You J; Li XC; Ghobrial RM; Kloc M
    Cell Immunol; 2016 Feb; 300():54-62. PubMed ID: 26711331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipopolysaccharide increases monocyte binding to mesangial cells through fractalkine and its receptor.
    Park J; Song KH; Ha H
    Transplant Proc; 2012 May; 44(4):1029-31. PubMed ID: 22564617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-6 receptor signaling disruption prevents cardiac allograft deterioration in mice.
    Iida S; Omoto K; Kanemitsu I; Setoguchi K; Ishida H; Tanabe K; Suzuki T; Tashiro Y; Kishimoto H; Abe R
    Exp Clin Transplant; 2012 Aug; 10(4):375-85. PubMed ID: 22758208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abrogation of chronic rejection in rat model system involves modulation of the mTORC1 and mTORC2 pathways.
    Zhang L; You J; Sidhu J; Tejpal N; Ganachari M; Skelton TS; Kloc M; Li XC; Ghobrial RM
    Transplantation; 2013 Nov; 96(9):782-90. PubMed ID: 23985719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Expression of Long Noncoding RNAs During Cardiac Allograft Rejection.
    Gu G; Huang Y; Wu C; Guo Z; Ma Y; Xia Q; Awasthi A; He X
    Transplantation; 2017 Jan; 101(1):83-91. PubMed ID: 27575691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse macrophages completely lacking Rho subfamily GTPases (RhoA, RhoB, and RhoC) have severe lamellipodial retraction defects, but robust chemotactic navigation and altered motility.
    Königs V; Jennings R; Vogl T; Horsthemke M; Bachg AC; Xu Y; Grobe K; Brakebusch C; Schwab A; Bähler M; Knaus UG; Hanley PJ
    J Biol Chem; 2014 Oct; 289(44):30772-30784. PubMed ID: 25213860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection.
    Gao W; Topham PS; King JA; Smiley ST; Csizmadia V; Lu B; Gerard CJ; Hancock WW
    J Clin Invest; 2000 Jan; 105(1):35-44. PubMed ID: 10619859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haptoglobin enhances cardiac transplant rejection.
    Shen H; Heuzey E; Mori DN; Wong CK; Colangelo CM; Chung LM; Bruce C; Slizovskiy IB; Booth CJ; Kreisel D; Goldstein DR
    Circ Res; 2015 May; 116(10):1670-9. PubMed ID: 25801896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCR4-deficient mice show prolonged graft survival in a chronic cardiac transplant rejection model.
    Hüser N; Tertilt C; Gerauer K; Maier S; Traeger T; Assfalg V; Reiter R; Heidecke CD; Pfeffer K
    Eur J Immunol; 2005 Jan; 35(1):128-38. PubMed ID: 15593118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene transfer of the S24F regulated on activation normal T-cell expressed and secreted-chemokine ligand 5 variant attenuates cardiac allograft rejection.
    Sun Y; Feng J; Shi J; Lu X; Xie A; Chen Y; Dong N
    Transplantation; 2014 Jun; 97(12):1233-9. PubMed ID: 24825519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary arteriosclerosis after T-cell-mediated injury in transplanted mouse hearts: role of interferon-gamma.
    Nagano H; Libby P; Taylor MK; Hasegawa S; Stinn JL; Becker G; Tilney NL; Mitchell RN
    Am J Pathol; 1998 May; 152(5):1187-97. PubMed ID: 9588888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fractalkine receptor CX₃CR1 protects against liver fibrosis by controlling differentiation and survival of infiltrating hepatic monocytes.
    Karlmark KR; Zimmermann HW; Roderburg C; Gassler N; Wasmuth HE; Luedde T; Trautwein C; Tacke F
    Hepatology; 2010 Nov; 52(5):1769-82. PubMed ID: 21038415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.